Sales and Marketing

Eli Lilly Shanghai, an affiliate of the wider company, has enlisted the help of biopharma firm Hutchinson China MediTech, or …

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has given its backing to Kyowa Kirin’s …

The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …

AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …

Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA) to support …

Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country …

Kite Pharma has chalked up another regulatory success for its parent company Gilead with the news that the FDA has …

AstraZeneca has secured two new recommendations for approval of its products from the European Medicines Agency’s Committee for Medicinal Products …

As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …

Rhythm Pharmaceuticals have appointed David Meeker, M.D., as its Chief Executive Officer and President of the company. Meeker succeeds interim …

Novavax, one of the leading US firms which is developing a coronavirus vaccine, is set to award executives stock options …

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …

An Israeli doctor has appeared to have contracted COVID-19 for a second time after they tested positive for the virus …